Literature DB >> 27865452

CYP2A6 Genetic Variation Alters Striatal-Cingulate Circuits, Network Hubs, and Executive Processing in Smokers.

Sufang Li1, Yihong Yang1, Ewa Hoffmann2, Rachel F Tyndale2, Elliot A Stein3.   

Abstract

BACKGROUND: Variation in the CYP2A6 gene alters the rate of nicotine metabolic inactivation and is associated with smoking behaviors and cessation success rates. The underlying neurobiological mechanisms of this genetic influence are unknown.
METHODS: Intrinsic functional connectivity strength, a whole-brain, data-driven, graph theory-based method, was applied to resting-state functional magnetic resonance imaging data in 66 smokers and 92 nonsmokers. A subset of subjects (n = 23/20; smokers/nonsmokers) performed the monetary incentive delay task, probing reward anticipation, and a go/no-go task, probing response inhibition, on two occasions, in the presence and absence of a nicotine patch.
RESULTS: A significant CYP2A6 genotype × smoking effect was found in the dorsal anterior cingulate cortex and ventral striatum, such that the normal (vs. slow) genotype individuals showed greater functional connectivity strength among smokers but not nonsmokers. Functional connectivity strength was negatively associated with severity of nicotine dependence in slow metabolizers. Both hubs were biased by inputs from the insula identified from seed-based connectivity. Similar gene × environment interactions were seen in ventral striatum during smoking abstinence when subjects performed the monetary incentive delay task and in dorsal anterior cingulate cortex when they performed the go/no-go task; both reductions were "normalized" in smokers (and increased in nonsmokers) after acute nicotine administration.
CONCLUSIONS: Because the CYP2A6 effect was seen only in smokers, these data suggest that the rate of nicotine metabolism-and thus the concentration of nicotine presented to the brain over the course of nicotine addiction-shapes brain circuits that, among other functions, compute reward and impulsivity processes. Published by Elsevier Inc.

Entities:  

Keywords:  CYP2A6 genotype; Functional connectivity strength; Neuroadaptations; Nicotine; Smoking; Striatal-cingulate-insula circuits

Mesh:

Substances:

Year:  2016        PMID: 27865452      PMCID: PMC5346346          DOI: 10.1016/j.biopsych.2016.09.013

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  66 in total

1.  Addiction becomes a brain disease.

Authors:  R A Wise
Journal:  Neuron       Date:  2000-04       Impact factor: 17.173

2.  Toward personalized therapy for smoking cessation: a randomized placebo-controlled trial of bupropion.

Authors:  F Patterson; R A Schnoll; E P Wileyto; A Pinto; L H Epstein; P G Shields; L W Hawk; R F Tyndale; N Benowitz; C Lerman
Journal:  Clin Pharmacol Ther       Date:  2008-04-02       Impact factor: 6.875

Review 3.  The reward circuit: linking primate anatomy and human imaging.

Authors:  Suzanne N Haber; Brian Knutson
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

4.  Anterior cingulate cortex, error detection, and the online monitoring of performance.

Authors:  C S Carter; T S Braver; D M Barch; M M Botvinick; D Noll; J D Cohen
Journal:  Science       Date:  1998-05-01       Impact factor: 47.728

Review 5.  How fast and how often: The pharmacokinetics of drug use are decisive in addiction.

Authors:  Florence Allain; Ellie-Anna Minogianis; David C S Roberts; Anne-Noël Samaha
Journal:  Neurosci Biobehav Rev       Date:  2015-06-24       Impact factor: 8.989

6.  Subprocesses of performance monitoring: a dissociation of error processing and response competition revealed by event-related fMRI and ERPs.

Authors:  M Ullsperger; D Y von Cramon
Journal:  Neuroimage       Date:  2001-12       Impact factor: 6.556

7.  Dissociable roles of ventral and dorsal striatum in instrumental conditioning.

Authors:  John O'Doherty; Peter Dayan; Johannes Schultz; Ralf Deichmann; Karl Friston; Raymond J Dolan
Journal:  Science       Date:  2004-04-16       Impact factor: 47.728

8.  Xenobiotic-metabolizing enzymes and transporters in the normal human brain: regional and cellular mapping as a basis for putative roles in cerebral function.

Authors:  Fabien Dutheil; Sandrine Dauchy; Monique Diry; Véronique Sazdovitch; Olivier Cloarec; Lucille Mellottée; Ivan Bièche; Magnus Ingelman-Sundberg; Jean-Pierre Flinois; Isabelle de Waziers; Philippe Beaune; Xavier Declèves; Charles Duyckaerts; Marie-Anne Loriot
Journal:  Drug Metab Dispos       Date:  2009-04-09       Impact factor: 3.922

9.  Risk-dependent reward value signal in human prefrontal cortex.

Authors:  Philippe N Tobler; George I Christopoulos; John P O'Doherty; Raymond J Dolan; Wolfram Schultz
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-15       Impact factor: 11.205

Review 10.  Fronto-striatal circuits in response-inhibition: Relevance to addiction.

Authors:  Sharon Morein-Zamir; Trevor W Robbins
Journal:  Brain Res       Date:  2014-09-16       Impact factor: 3.252

View more
  16 in total

1.  Classifying and characterizing nicotine use disorder with high accuracy using machine learning and resting-state fMRI.

Authors:  Reagan R Wetherill; Hengyi Rao; Nathan Hager; Jieqiong Wang; Teresa R Franklin; Yong Fan
Journal:  Addict Biol       Date:  2018-06-27       Impact factor: 4.280

2.  Network Analysis of Intrinsic Functional Brain Connectivity in Male and Female Adult Smokers: A Preliminary Study.

Authors:  Megan M Moran-Santa Maria; Davy C Vanderweyen; Christopher C Camp; Xun Zhu; Sherry A McKee; Kelly P Cosgrove; Karen J Hartwell; Kathleen T Brady; Jane E Joseph
Journal:  Nicotine Tob Res       Date:  2018-06-07       Impact factor: 4.244

3.  Novel CYP2A6 diplotypes identified through next-generation sequencing are associated with in-vitro and in-vivo nicotine metabolism.

Authors:  Julie-Anne Tanner; Andy Z Zhu; Katrina G Claw; Bhagwat Prasad; Viktoriya Korchina; Jianhong Hu; HarshaVardhan Doddapaneni; Donna M Muzny; Erin G Schuetz; Caryn Lerman; Kenneth E Thummel; Steven E Scherer; Rachel F Tyndale
Journal:  Pharmacogenet Genomics       Date:  2018-01       Impact factor: 2.089

4.  Brain Gray Matter Volume and Functional Connectivity Are Associated With Smoking Cessation Outcomes.

Authors:  Wei Qian; Peiyu Huang; Zhujing Shen; Chao Wang; Yihong Yang; Minming Zhang
Journal:  Front Hum Neurosci       Date:  2019-10-15       Impact factor: 3.169

5.  Compulsive drug use is associated with imbalance of orbitofrontal- and prelimbic-striatal circuits in punishment-resistant individuals.

Authors:  Yuzheng Hu; Betty Jo Salmeron; Irina N Krasnova; Hong Gu; Hanbing Lu; Antonello Bonci; Jean L Cadet; Elliot A Stein; Yihong Yang
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-15       Impact factor: 11.205

6.  Intrinsic Insular-Frontal Networks Predict Future Nicotine Dependence Severity.

Authors:  Li-Ming Hsu; Robin J Keeley; Xia Liang; Julia K Brynildsen; Hanbing Lu; Yihong Yang; Elliot A Stein
Journal:  J Neurosci       Date:  2019-04-16       Impact factor: 6.167

Review 7.  Functional Neurocircuits and Neuroimaging Biomarkers of Tobacco Use Disorder.

Authors:  Matthew T Sutherland; Elliot A Stein
Journal:  Trends Mol Med       Date:  2018-02       Impact factor: 11.951

8.  The Effects of Nicotine and Tobacco Use on Brain Reward Function: Interaction With Nicotine Dependence Severity.

Authors:  Merideth A Addicott; Maggie M Sweitzer; F Joseph McClernon
Journal:  Nicotine Tob Res       Date:  2019-05-21       Impact factor: 4.244

9.  Intrinsic differences in insular circuits moderate the negative association between nicotine dependence and cingulate-striatal connectivity strength.

Authors:  Robin J Keeley; Li-Ming Hsu; Julia K Brynildsen; Hanbing Lu; Yihong Yang; Elliot A Stein
Journal:  Neuropsychopharmacology       Date:  2020-02-13       Impact factor: 7.853

Review 10.  Alterations in resting-state functional connectivity in substance use disorders and treatment implications.

Authors:  Claire E Wilcox; Christopher C Abbott; Vince D Calhoun
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2018-06-25       Impact factor: 5.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.